F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comEvexia Lifecare Ltd is a micro-cap pharmaceutical and healthcare-related company that has attracted market attention due to its high trading volumes, foreign institutional participation, and low stock price base. The company operates in a highly competitive sector where scale, compliance, and execution play a critical role in long-term success.
While Evexia Lifecare Ltd carries high volatility and risk, it also presents a speculative turnaround and momentum-driven opportunity for investors with a higher risk appetite. In this article, we analyze Evexia Lifecare Ltd share price targets from 2026 to 2030 using current market data, ownership structure, valuation metrics, and sector outlook.
| Detail | Value |
|---|---|
| Open | ₹1.65 |
| Previous Close | ₹1.63 |
| Day’s High | ₹1.67 |
| Day’s Low | ₹1.62 |
| VWAP | ₹1.64 |
| 52-Week High | ₹3.15 |
| 52-Week Low | ₹1.50 |
| All-Time High | ₹17.00 |
| All-Time Low | ₹0.09 |
| Market Capitalization | ₹306 Cr |
| Volume | 18,70,085 |
| Value (Lacs) | ₹30.48 |
| Face Value | ₹1 |
| Book Value Per Share | ₹2.21 |
| Beta | 1.17 |
| UC Limit | ₹1.95 |
| LC Limit | ₹1.31 |
| 20D Avg Volume | 36,24,543 |
| 20D Avg Delivery (%) | 79.91 |
Evexia Lifecare Ltd operates in the healthcare and pharmaceutical space, with activities linked to trading, distribution, and allied healthcare segments. The company has undergone multiple strategic and structural changes over the years, which is reflected in its wide historical price range.
At present, Evexia Lifecare is positioned as a high-risk, high-volatility micro-cap stock, where share price movement is influenced more by liquidity, sentiment, and execution updates than by stable long-term earnings visibility.
Presence in the healthcare and pharmaceutical domain
Strong trading liquidity relative to market capitalization
Stock trading below book value per share
Significant foreign institutional participation
High delivery percentage indicating positional interest
Evexia Lifecare Ltd stands out due to its unusual shareholding pattern, where foreign institutions hold a substantial stake, despite the company’s small size. This suggests either long-term optionality or event-driven positioning.
However, the company also faces:
Thin operating margins
Limited publicly visible earnings consistency
High dependence on market sentiment
For such stocks, price movement can be sharp in both directions, and long-term outcomes depend heavily on management execution and regulatory compliance.
| Investor Type | Holding (%) |
|---|---|
| Retail & Others | 50.93% |
| Foreign Institutions | 45.48% |
| Promoters | 3.49% |
| Other Domestic Institutions | 0.07% |
| Mutual Funds | 0.02% |
Low promoter holding increases risk, while high FII participation adds volatility and momentum sensitivity.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2026 | 2.20 | 3.00 |
| 2027 | 3.20 | 4.50 |
| 2028 | 4.80 | 6.50 |
| 2029 | 7.00 | 9.50 |
| 2030 | 10.00 | 14.00 |
These projections assume business continuity, improved disclosures, and sustained liquidity, not aggressive growth assumptions.
By 2026, the stock may attempt to align closer to its book value if operational stability improves.
Growth Drivers:
Continued trading liquidity
Improved financial visibility
Investment View: High-risk speculative entry zone.
Market re-rating could occur if revenue consistency improves.
Growth Drivers:
Higher delivery-based accumulation
Improved corporate governance signals
Investment View: Only for risk-tolerant investors.
By 2028, Evexia may benefit from healthcare sector tailwinds.
Growth Drivers:
Sector recovery
Potential restructuring or expansion
Investment View: Momentum + turnaround play.
Sustained operations could support gradual valuation expansion.
Growth Drivers:
Market confidence
Stable regulatory compliance
Investment View: Partial profit-booking zone advised.
If the company successfully stabilizes its business model, long-term price appreciation is possible.
Growth Drivers:
Improved earnings quality
Re-rating from penny stock category
Investment View: High reward but equally high risk.
Evexia Lifecare Ltd is not a conventional long-term compounder. It is better classified as a speculative micro-cap healthcare stock, suitable only for investors who understand liquidity risk, governance risk, and volatility.
Trading below book value
High FII participation
Strong volume and delivery data
Healthcare sector exposure
Very low promoter holding
Earnings unpredictability
Regulatory and compliance risk
Sharp price swings
Evexia Lifecare Ltd offers asymmetric upside potential, but it comes with significant downside and execution risk. If business stability improves and governance remains transparent, the stock could gradually move toward ₹10–₹14 by 2030.
However, this stock is best suited for experienced investors with strict position sizing and risk management, not conservative long-term portfolios.
1. What is the current share price of Evexia Lifecare Ltd?
It trades near the levels mentioned in the latest market data and fluctuates actively.
2. What is the expected share price target for 2026?
The estimated range for 2026 is ₹2.20 to ₹3.00.
3. Is Evexia Lifecare Ltd a safe long-term investment?
No, it is a high-risk micro-cap stock and should be treated as speculative.
4. What is the share price target for 2030?
The projected range is ₹10.00 to ₹14.00, subject to execution and market conditions.
5. What factors influence the share price the most?
Liquidity, foreign investor activity, business updates, and market sentiment.
Disclaimer:
This article is for educational purposes only and does not constitute investment advice. Penny and micro-cap stocks involve high risk. Please consult a certified financial advisor before investing.
Register & Login